Search Within

Dan Douer

Formats
  1. Journal Article (45)
  2. Meeting Abstract (41)
  3. Book Section (1)
Groups
  1. Department of Medicine (87)
  2. Hematologic Malignancies, Division of (87)
  3. Center for Hematologic Malignancies (60)
  4. Adult Leukemia (58)
  5. Biostatistics Service (20)
  6. Epidemiology and Biostatistics (20)

More Groups

People
  1. Martin Tallman (50)
  2. Jae Park (29)
  3. Sean Devlin (16)
  4. Peter Maslak (9)
  5. Ross Levine (9)
  6. Eytan Stein (7)

More People

Years
  1. 2021 (2)
  2. 2020 (1)
  3. 2018 (4)
  4. 2017 (3)
  5. 2016 (16)
  6. 2015 (15)

More Years

Publications
  1. Blood (38)
  2. Leukemia Research (7)
  3. Journal of Clinical Oncology (6)
  4. Acta Haematologica (4)
  5. Clinical Advances in Hematology & Oncology (4)
  6. Best Practice and Research: Clinical Haematology (3)

More Publications

Publishers
  1. American Society of Hematology (39)
  2. Elsevier Ltd (7)
  3. American Society of Clinical Oncology (6)
  4. Elsevier Inc. (6)
  5. Millennium Medical Publishing, Inc (4)
  6. S. Karger AG (4)

More Publishers

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase II trial of WT1 analog peptide vaccine in adults with acute myeloid leukemia (AML) in first complete remission (CR)
    Meeting Abstract

    Maslak, P. G.; Dao, T.; Bernal, Y.; Chanel, S. M.; Zhang, R.; Frattini, M. G.; Rosenblat, T. L.; Jurcic, J. G.; Rampal, R.; Park, J. H.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Outcomes of patients 60 and older with ALL: Analysis of the SEER database
    Meeting Abstract

    Geyer, M. B.; Hsu, M.; Devlin, S.; Douer, D.; Park, J. H.
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • A pediatric-inspired regimen containing multiple doses of intravenous pegylated asparaginase appears safe and effective in newly diagnosed adult patients with Ph-negative acute lymphoblastic leukemia in adults up to age 60: Results of a multi-center phase II clinical trial
    Meeting Abstract

    Park, J. H.; Ritchie, E. K.; Rao, A. V.; Devlin, S.; Hsu, M.; Khawaja, T. T.; O'Donnell, B. A.; Cazacu, M. I.; Stopka, D. M.; Tallman, M. S.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Impact of treatment center characteristics on early death rates in patients with newly diagnosed acute promyelocytic leukemia: Analysis of data from the SEER program
    Meeting Abstract

    Park, J. H.; Devlin, S.; Lynch, C.; Schwartz, A.; Keegan, T.; Gonsalves, L.; Hermit, K.; Green, M.; Douer, D.; Tallman, M. S.
    Blood (2016)

    Fulltext@MSK | Save
  • Clinical relevant alterations identified by comprehensive genomic profiling can potentially improve therapeutic option and change prognosis in hematologic malignancies
    Meeting Abstract

    He, J.; Patel, M.; Phillip, I.; Bailey, M.; Berman, E.; Park, J. H.; Shukla, N. N.; Chung, S. S.; Castro-Malaspina, H.; Douer, D.; more...
    Blood (2016)

    Fulltext@MSK | Save
  • Novel approaches for the interim management of relapsed/refractory acute lymphocytic leukemia: A case-study compendium
    Journal Article

    Wang, E. S.; Jabbour, E. J.; Douer, D.
    Clinical Advances in Hematology & Oncology (2016)

    Fulltext@MSK | Save
  • Autologous transplant remains the preferred therapy for relapsed APL in CR2
    Journal Article

    Ganzel, C.; Mathews, V.; Alimoghaddam, K.; Ghavamzadeh, A.; Kuk, D.; Devlin, S.; Wang, H.; Zhang, M. J.; Weisdorf, D.; Douer, D.; more...
    Bone Marrow Transplantation (2016)

    Fulltext@MSK | Save
  • Hypoalbuminemia is significantly associated with increased clearance time of high dose methotrexate in patients being treated for lymphoma or leukemia
    Journal Article

    Reiss, S. N.; Buie, L. W.; Adel, N.; Goldman, D. A.; Devlin, S. M.; Douer, D.
    Annals of Hematology (2016)

    Fulltext@MSK | Save
  • A Phase 1 study of intravenous infusions of tigecycline in patients with acute myeloid leukemia
    Journal Article

    Reed, G. A.; Schiller, G. J.; Kambhampati, S.; Tallman, M. S.; Douer, D.; Minden, M. D.; Yee, K. W.; Gupta, V.; Brandwein, J.; Jitkova, Y.; more...
    Cancer Medicine (2016)

    Fulltext@MSK | Save
  • Extramedullary disease in adult acute myeloid leukemia is common but lacks independent significance: Analysis of patients in ECOG-ACRIN Cancer Research Group trials, 1980-2008
    Journal Article

    Ganzel, C.; Manola, J.; Douer, D.; Rowe, J. M.; Fernandez, H. F.; Paietta, E. M.; Litzow, M. R.; Lee, J. W.; Luger, S. M.; Lazarus, H. M.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save